ワクチン送達デバイス市場：性質別、製品タイプ別-2025～2030年の世界予測

ワクチン送達デバイス市場の2023年の市場規模は69億3,000万米ドルで、2024年には76億2,000万米ドルに達すると予測され、CAGR 10.39%で成長し、2030年には138億5,000万米ドルに達すると予測されています。

ワクチン送達デバイス市場の範囲と定義には、注射器、ジェットインジェクター、マイクロニードルパッチなど、ワクチン投与に不可欠な器具や技術が含まれます。これらの機器の必要性は、ワクチン開発の急速な進歩や世界の予防接種プログラムの重視によってもたらされています。ワクチン送達デバイスは、ワクチンの効果的な投与を保証し、無駄を最小限に抑え、患者のコンプライアンスを高める上で極めて重要です。その用途は幅広く、病院、診療所、さらには在宅医療環境にまで及び、自己投与法への依存も高まっています。エンドユーザーは主にヘルスケアプロバイダー、政府機関、予防医療分野の個人などです。

同市場の主な成長要因には、針を使わないドラッグデリバリー・システムなどの技術進歩、ワクチン接種率の上昇、パンデミック対策への注目の高まりなどがあります。最新の潜在的ビジネスチャンスは、追跡と管理の効率を高めることができるデジタルヘルスケアソリューションの統合にあります。新興市場は、ヘルスケア・インフラの改善や予防接種率向上のための政府イニシアチブの増加により、大きな成長の可能性を秘めています。しかし、厳しい規制の枠組み、革新的な送達デバイスに関連する高コスト、ワクチン接種のためらいといった課題が、市場の成長を阻害する可能性があります。

革新と研究は、ワクチン接種の状況を一変させる可能性のある、皮膚パッチや摂取可能な装置など、費用対効果が高く、便利で苦痛のない送達方法の開発に向けられるのが最善です。市場は非常にダイナミックで競合が多いため、企業はイノベーションと市場浸透を促進するためにパートナーシップやコラボレーションに注力すべきです。ワクチン投与の正確な追跡とモニタリングのためのIoTとAIを活用した研究開発の強化も、市場に大きな優位性をもたらす可能性があります。全体として、市場は規制のハードルとコストに関連する課題に直面しているが、痛みのない自己投与ワクチンへの取り組みとデジタルヘルスケアの統合は、成長とイノベーションのための肥沃な土壌を提供します。

市場力学：急速に進化するワクチン送達デバイス市場の主要市場インサイトを公開

ワクチン送達デバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患と手術件数の増加
  • 予防接種プログラムの増加、ワクチン接種イニシアチブとキャンペーンの拡大
  • 新規ワクチン開発に対する政府の戦略的投資
• 市場抑制要因
  • 保管のための適切なインフラの欠如と高コスト
• 市場機会
  • 針を使わない技術など、新しいワクチン送達技術の採用
  • 安全なワクチン送達のための新デバイスの開発
• 市場の課題
  • 感染リスクと血液媒介感染症のトランスミッション

ポーターの5つの力：ワクチン送達デバイス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ワクチン送達デバイス市場における外部からの影響の把握

外部マクロ環境要因は、ワクチン送達デバイス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ワクチン送達デバイス市場における競合情勢の把握

ワクチン送達デバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスワクチン送達デバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ワクチン送達デバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ワクチン送達デバイス市場における成功への道筋を描く

ワクチン送達デバイス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患と手術件数の増加
    • 予防接種プログラムの増加、ワクチン接種の取り組みとキャンペーンの拡大
    • 新規ワクチン開発に対する政府の有利な戦略的投資
  • 抑制要因
    • 保管のための適切なインフラの欠如と高コスト
  • 機会
    • 針を使わない技術などの新しいワクチン投与技術の採用
    • 安全なワクチン投与のための新しいデバイスの開発
  • 課題
    • 感染および血液媒介感染症のトランスミッションのリスク
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ワクチン送達デバイス市場自然別

• 針ベース
• 針なし

第7章 ワクチン送達デバイス市場：製品タイプ別

• ジェットインジェクター
• マイクロニードル
• 注射器

第8章 南北アメリカのワクチン送達デバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のワクチン送達デバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのワクチン送達デバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 3M Company
• Antares Pharma, Inc. by Halozyme, Inc.
• Becton Dickinson & Company
• Corium, Inc.
• Gerresheimer AG
• Inovio Pharmaceuticals, Inc.
• Johnson & Johnson Services, Inc.
• Medical International Technologies（MIT Canada）Inc.
• Medline Industries, LP
• PharmaJet, Inc.
• Recipharm AB
• Schott AG
• Smith & Nephew PLC
• Terumo Corporation
• Viatris Inc.

LIST OF FIGURES

• FIGURE 1. VACCINE DELIVERY DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. VACCINE DELIVERY DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. VACCINE DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. VACCINE DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VACCINE DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VACCINE DELIVERY DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY NEEDLE BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY NEEDLE-LESS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY JET INJECTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY SYRINGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 21. CANADA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 22. CANADA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 33. CHINA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 34. CHINA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. INDIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 36. INDIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. ITALY VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 71. ITALY VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. POLAND VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 79. POLAND VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. QATAR VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 81. QATAR VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. VACCINE DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. VACCINE DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Vaccine Delivery Devices Market was valued at USD 6.93 billion in 2023, expected to reach USD 7.62 billion in 2024, and is projected to grow at a CAGR of 10.39%, to USD 13.85 billion by 2030.

The scope and definition of the vaccine delivery devices market encompass a range of instruments and technologies essential for the administration of vaccines, including syringes, jet injectors, and microneedle patches. The necessity for these devices is driven by the rapid advancements in vaccine development and the global emphasis on immunization programs. Vaccine delivery devices are crucial in ensuring the effective administration of vaccines, minimizing wastage, and enhancing patient compliance. Their applications are broad, spanning hospitals, clinics, and even at-home healthcare settings, with an increasing reliance on self-administration methods. End-users primarily include healthcare providers, governmental agencies, and individuals in areas of preventive healthcare.

Key growth factors in the market include technological advancements like needle-free drug delivery systems, rising vaccination coverage, and an increased focus on pandemic preparedness. Latest potential opportunities lie in the integration of digital healthcare solutions which can enhance tracking and administration efficiency. Emerging markets offer significant growth possibilities due to improved healthcare infrastructure and increasing government initiatives to boost immunization rates. However, challenges such as stringent regulatory frameworks, high costs associated with innovative delivery devices, and vaccine hesitancy can impede market growth.

Innovation and research are best directed towards developing cost-effective, convenient, and painless delivery methods, such as skin patches or ingestible devices, which could revolutionize the vaccination landscape. As the market is highly dynamic and competitive, businesses should focus on partnerships and collaborations to foster innovation and market penetration. Enhanced R&D efforts utilizing IoT and AI for precise tracking and monitoring of vaccine administration can also present significant market advantages. Overall, while the market faces challenges related to regulatory hurdles and cost, the push towards painless, self-administration vaccines, coupled with digital healthcare integration, provides a fertile ground for growth and innovation.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vaccine Delivery Devices Market

The Vaccine Delivery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing chronic diseases and number of surgeries
  • Rising immunization programs, growing vaccination initiatives & campaigns
  • Favorable government strategic investment for the development of novel vaccines
• Market Restraints
  • Lack of proper infrastructure for storage and high costs
• Market Opportunities
  • Adoption of novel vaccine delivery technologies such as needle-free technologies
  • Developments of new devices for safe vaccine delivery
• Market Challenges
  • Risk of infections and transmission of blood-borne infections

Porter's Five Forces: A Strategic Tool for Navigating the Vaccine Delivery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vaccine Delivery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vaccine Delivery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vaccine Delivery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vaccine Delivery Devices Market

A detailed market share analysis in the Vaccine Delivery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vaccine Delivery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vaccine Delivery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vaccine Delivery Devices Market

A strategic analysis of the Vaccine Delivery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vaccine Delivery Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Antares Pharma, Inc. by Halozyme, Inc., Becton Dickinson & Company, Corium, Inc., Gerresheimer AG, Inovio Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Medical International Technologies (MIT Canada) Inc., Medline Industries, LP, PharmaJet, Inc., Recipharm AB, Schott AG, Smith & Nephew PLC, Terumo Corporation, and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Vaccine Delivery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Nature, market is studied across Needle Based and Needle-Less.
• Based on Product Type, market is studied across Jet Injectors, Microneedles, and Syringes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing chronic diseases and number of surgeries
    • 5.1.1.2. Rising immunization programs, growing vaccination initiatives & campaigns
    • 5.1.1.3. Favorable government strategic investment for the development of novel vaccines
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of proper infrastructure for storage and high costs
  • 5.1.3. Opportunities
    • 5.1.3.1. Adoption of novel vaccine delivery technologies such as needle-free technologies
    • 5.1.3.2. Developments of new devices for safe vaccine delivery
  • 5.1.4. Challenges
    • 5.1.4.1. Risk of infections and transmission of blood-borne infections
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Vaccine Delivery Devices Market, by Nature

• 6.1. Introduction
• 6.2. Needle Based
• 6.3. Needle-Less

7. Vaccine Delivery Devices Market, by Product Type

• 7.1. Introduction
• 7.2. Jet Injectors
• 7.3. Microneedles
• 7.4. Syringes

8. Americas Vaccine Delivery Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Vaccine Delivery Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Vaccine Delivery Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Antares Pharma, Inc. by Halozyme, Inc.
• 3. Becton Dickinson & Company
• 4. Corium, Inc.
• 5. Gerresheimer AG
• 6. Inovio Pharmaceuticals, Inc.
• 7. Johnson & Johnson Services, Inc.
• 8. Medical International Technologies (MIT Canada) Inc.
• 9. Medline Industries, LP
• 10. PharmaJet, Inc.
• 11. Recipharm AB
• 12. Schott AG
• 13. Smith & Nephew PLC
• 14. Terumo Corporation
• 15. Viatris Inc.